Twist Bioscience Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TWST | 1548.HK | MRVI | 688222.SS | 301080.SZ | 600645.SS | |
|---|---|---|---|---|---|---|
| Market cap | 9.45B | 76.81B | 2.86B | 15.37B | 16.17B | 8.36B |
| P/E (TTM) | — | — | — | 98.3 | 83.1 | 74.4 |
| Forward P/E | -356.5 | 85.8 | -76.7 | 70.3 | — | 40.6 |
| Price/book | 20.0 | 2.4 | 5.3 | 9.4 | 5.9 | 2.1 |
| Dividend yield | — | — | — | 0.37% | 0.63% | — |
| 1-year change | +345.11% | +109.10% | +159.58% | +48.44% | +57.00% | −29.27% |
| Today | +1.63% | −0.94% | +3.62% | +7.61% | +1.77% | +1.94% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TWST news ›MoleculeMind's New MMDesign Technical Report Demonstrates 94.7% Campaign Success Rate Across Diverse Molecular Targets and Modalities
High success rates with limited experimental screening Successful binder discovery across six challenging GPCR targets All 30 tested candidates produced positive binding results for NK3R, a 100% hit rate. For GPR68, 10 of 11 candidates…
Why Is Competitive ELISA the Only Option for Small‑Molecule Detection?
The National Law Review Why Is Competitive ELISA the Only Option for Small‑Molecule Detection? Unpacking Five Key Development Barriers of Competitive ELISA and Cloud‑Clone’s Full‑Link Technical Breakthroughs HUSTON, TX, UNITED S
Twist Bioscience Soars 12%, 10x Genomics Up 12% as Genomics Stocks Rebound
max-kegfire from Getty Images via Canva Twist Bioscience (TWST) stock jumped 12% today, and 10x Genomics (TXG) rose 12% right alongside it. Neither company had news to explain the move. Twist’s only release was the launch of a new…
Twist Bioscience Launches Custom MRD Panels for Cancer Assay Development
Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting within one day. The new platform offers custom panel manufacturing in as little as one day to support development…
Twist Bioscience (TWST) Gets a Buy from Leerink Partners
Leerink Partners analyst Puneet Souda maintained a Buy rating on Twist Bioscience today and set a price target of $190.00. Souda covers the Healthcare sector, focusing on stocks such as Twist Bioscience, 10x Genomics, and Bruker. According…
ARKG: Revolutionary Science, Unremarkable Returns
The ARK Genomic Revolution ETF is rated a HOLD with MODERATE conviction, given high valuations and moderate expected returns. Read more here on ARKG. - I rate ARK Genomic Revolution ETF a HOLD with MODERATE conviction, given high…
Twist Bioscience Expands High-Throughput Antibody Characterization with Launch of Express Screening Antibodies
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
AlphaFold 3 Structures Can Guide T-Cell Receptor Engineering, With Caveats
A benchmark of 438 TCR–pMHC mutations shows experimental structures remain the best input for binding-affinity predictors, while AlphaFold 3 mutant scaffolds offer a useful fallback for top-candidate recovery. Article Title: Mutational…
Research Analysts’ Weekly Ratings Changes for Twist Bioscience (TWST)
Twist Bioscience (NASDAQ: TWST) recently received a number of ratings updates from brokerages and research firms: 10/13/2026 – Twist Bioscience had its price target raised by TD Cowen from $115.00 to $190.00. They now have a “buy” rating…
Twist Bioscience Sinks 9%, Illumina Down 5% as AI and Genomics Stocks Slide
@Delia Pindaru's Images via Canva Twist Bioscience (TWST) shares are down 9% today, and the company didn’t even do anything to deserve it this time. It has company. Illumina (ILMN) is down 5% as the tech-heavy Nasdaq slid more than 2%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net14
- defenseworld.net4
- stockstotrade.com4
- timothysykes.com3
- seekingalpha.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 38 articles, not a forecast.